The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure-activity relationship of imidazopyridinium analogues as antagonists of neuropeptide s receptor.EBI
National Institutes of Health
Conformation-activity relationship of neuropeptide S and some structural mutants: helicity affects their interaction with the receptor.EBI
Istituto Di Chimica Biomolecolare
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68).EBI
University of Ferrara
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.EBI
National Institute of Neuroscienc
Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists.EBI
University of Ferrara
Tricyclic imidazole antagonists of the Neuropeptide S Receptor.EBI
Merck Research Laboratories
Synthesis and pharmacological characterization of 5-phenyl-2-[2-(1-piperidinylcarbonyl)phenyl]-2,3-dihydro-1H-pyrrolo[1,2-c]imidazol-1-ones: a new class of Neuropeptide S antagonists.EBI
Glaxosmithkline
Synthesis and evaluation of a new series of Neuropeptide S receptor antagonists.EBI
Merck Research Laboratories
Structure-Activity Relationship Studies on Oxazolo[3,4-EBI
University of Ferrara
Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity.EBI
University of Florida
Structure-activity study at positions 3 and 4 of human neuropeptide S.EBI
University of Ferrara
Synthesis and biological activity of human neuropeptide S analogues modified in position 2.EBI
University of Ferrara